DynaGen appoints general manager for Able Laboratories.CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 14, 1996--DynaGen Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : DYGN; BSE See Bombay Stock Exchange. BSE See Boston Stock Exchange (BSE). : DYG) today announced that Susan M. Barrett has joined its wholly-owned subsidiary, Able Laboratories Inc. as general manager. Barrett brings to Able over 15 years of operations and sales and marketing experience in the multisource pharmaceutical industry. She has assumed direct responsibility for the daily operations of the Able Laboratories business. Since entering this industry as a customer service representative in 1981, Barrett has held increasingly senior positions in sales and marketing within the U.S. multisource pharmaceutical industry. She had also been director of sales for ALPHARMA from January 1993 to April 1995, the company from which DynaGen acquired Able Laboratories in August 1996. Most recently, Barrett has been a consultant to pharmaceutical wholesalers manufacturers in the areas of strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. and sales and marketing. "As General Manager of Able, I look forward to working with DyanGen's management team to implement its strategic plan for becoming a key player in the multisource pharmaceutical industry," said Barrett. Able Laboratories has 46,000 square feet of tablet and suppository suppository /sup·pos·i·to·ry/ (su-poz´i-tor?e) an easily fusible medicated mass to be introduced into a body orifice, as the rectum, urethra, or vagina. sup·pos·i·to·ry n. manufacturing. With the acquisition of Able, DynaGen also obtained the rights to ten ANDA ANDA abbr. abbreviated new drug application products, including tablet or capsule formulations of bisacodyl, clorazepate, phenazopyridine, choline choline: see vitamin. choline Organic compound related to vitamins in its activity. It is important in metabolism as a component of the lipids that make up cell membranes and of acetylcholine. magnesium trisalicylate, mandelamine and salsalate. DynaGen Inc., a healthcare company founded in 1988, develops and markets therapeutic and diagnostic products for human healthcare. CONTACT: Martin E. Janis & Co. Inc. Jim Janis, 312/943-1100 or DynaGen Inc. F. Howard Schneider Ph.D., 617/491-2527 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion